Legend Biotech (LEGN) EBT Margin (2019 - 2026)
Legend Biotech (LEGN) posted quarterly EBT Margin of 17.63% for Q1 2026, up 3324.0% year-on-year from 0.51% in Q1 2025, and down 174.17% on a QoQ basis from 6.43% in Q4 2025.
Legend Biotech (LEGN) EBT Margin (2019 - 2026) Analysis & Trends
Legend Biotech (LEGN) has reported EBT Margin for 8 consecutive years, with 17.63% the latest figure, recorded in Q1 2026.
- Quarterly EBT Margin rose 3324.0% year-over-year to 17.63% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.84% (up 627.0% YoY) and the FY2025 annual result came in at 27.47%, down 226.0% from the prior year.
- EBT Margin eased to 17.63% in Q1 2026 per LEGN's latest filing, from 6.43% in the prior quarter.
- Over the last five years, EBT Margin for LEGN reached as high as 21.77% in Q4 2024 and fell as low as 1612.82% in Q2 2022.
- A 5-year average of 199.29% and a median of 63.61% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin sank 76081 bps — and 2023, when it soared 134167 bps.
- Year by year, EBT Margin stood at 491.16% in 2022, then jumped by 100 bps to 0.18% in 2023, then surged by 11883 bps to 21.77% in 2024, then plunged by 130 bps to 6.43% in 2025, then sank by 174 bps to 17.63% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 17.63%, 6.43%, and 14.35% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Legend Biotech | 8.69 Bn | 7.79 Bn | 129.70 Mn | -17.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.63% |
| Dec 31, 2025 | -6.43% |
| Sep 30, 2025 | -14.35% |
| Jun 30, 2025 | -48.93% |
| Mar 31, 2025 | -50.87% |
| Dec 31, 2024 | 21.77% |
| Sep 30, 2024 | -75.46% |
| Jun 30, 2024 | -9.63% |
| Mar 31, 2024 | -63.61% |
| Dec 31, 2023 | -0.18% |
| Sep 30, 2023 | -65.09% |
| Jun 30, 2023 | -271.16% |
| Mar 31, 2023 | -308.16% |
| Dec 31, 2022 | -491.16% |
| Sep 30, 2022 | -309.94% |
| Jun 30, 2022 | -1,612.82% |
| Mar 31, 2022 | -64.20% |
| Dec 31, 2021 | -226.53% |
| Sep 30, 2021 | -738.96% |
| Jun 30, 2021 | -852.01% |